Immediate Impact
4 from Science/Nature 53 standout
Citing Papers
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
2024 Standout
Works of Matthew Onsum being referenced
Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma
2022
Single-Cell Quantitative HER2 Measurement Identifies Heterogeneity and Distinct Subgroups within Traditionally Defined HER2-Positive Patients
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Matthew Onsum | 304 | 299 | 87 | 214 | 24 | 619 | |
| Peter D. Caie | 242 | 205 | 83 | 145 | 35 | 661 | |
| Rosalin Mishra | 334 | 404 | 136 | 128 | 19 | 698 | |
| Edward H. van der Horst | 293 | 380 | 69 | 130 | 20 | 629 | |
| C. Moeder | 224 | 386 | 39 | 114 | 9 | 577 | |
| Rachele Alzani | 249 | 246 | 66 | 90 | 25 | 575 | |
| Diana Spiegelberg | 274 | 300 | 62 | 118 | 30 | 537 | |
| Kai Hauser | 183 | 314 | 171 | 152 | 28 | 736 | |
| Alexander Bolaender | 155 | 330 | 48 | 64 | 14 | 530 | |
| Samar Alanazi | 264 | 332 | 102 | 98 | 12 | 554 | |
| Daniel M. Freed | 177 | 327 | 69 | 114 | 17 | 565 |
All Works
Loading papers...